Candida auris: Outbreak, surveillance and epidemiological monitoring in Northern Greece

Aikaterina Poulopoulou; Anna Sidiropoulou; Theopisti Sarmourli; Evaggelia Zachrou; Chrysi Michailidou; Charalampos Zarras; Eleni Vagdatli; Eleni Massa; Eleni Mouloudi; Athina Pyrpasopoulou; Georgios Meletis; Efthymia Protonotariou; Lemonia Skoura; Simeon Metallidis; Theodoros Karampatakis; Eleni Katsifa; Anna Nikopoulou; Alexandra Louka; Artemisia Rizou; Kostoula Arvaniti; Vassili Kouvelis; Andrew Borman; Emmanuel Roilides; Timoleon Achilleas Vyzantiadis

doi:10.1093/mmy/myae062

Candida auris: Outbreak, surveillance and epidemiological monitoring in Northern Greece

Aikaterina Poulopoulou, Anna Sidiropoulou, Theopisti Sarmourli, Evaggelia Zachrou, Chrysi Michailidou, Charalampos Zarras, Eleni Vagdatli, Eleni Massa, Eleni Mouloudi, Athina Pyrpasopoulou, Georgios Meletis, Efthymia Protonotariou, Lemonia Skoura, Simeon Metallidis, Theodoros Karampatakis, Eleni Katsifa, Anna Nikopoulou, Alexandra Louka, Artemisia Rizou, Kostoula ArvanitiVassili Kouvelis, Andrew Borman, Emmanuel Roilides, Timoleon Achilleas Vyzantiadis^*

^*Corresponding author for this work

Bristol Mycology Reference Laboratory General

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Abstract

Candida auris is an emerging fungal pathogen associated with multi-drug resistance rates and widespread outbreaks in hospitals and healthcare units worldwide. Sequencing studies have revealed that different clonal lineages of the fungus seem to be prevalent among distinct geographical sites. The first case of C. auris in Northern Greece was reported in Thessaloniki in October 2022, almost 2 years after the first isolation in Greece (Athens 2019). The Mycology Laboratory of the Medical School of Aristotle University of Thessaloniki stands as the reference laboratory for fungal diseases in Northern Greece and a meticulous search for the yeast, in plenty of suspicious samples, has been run since 2019 in the Lab as well as a retrospective analysis of all its yeasts' collection, back to 2008, with negative results for the presence of C. auris. Here, are presented the findings concerning the outbreak and surveillance of C. auris in Northern Greece, mainly the region of Thessaloniki and the broader area of Macedonia, from October 2022 until August 2023. The isolates from Northern Greece continue to fall in Clade I and present with an almost equal and stable sensitivity profile until now.

Original language	English
Article number	myae062
Journal	Medical Mycology
Volume	62
Issue number	7
DOIs	https://doi.org/10.1093/mmy/myae062
Publication status	Published - 1 Jul 2024

Bibliographical note

Publisher Copyright:
© The Author(s) 2024.

Keywords

Candida auris
Greece
epidemiology
monitoring
outbreak

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/mmy/myae062

Cite this

Poulopoulou, A., Sidiropoulou, A., Sarmourli, T., Zachrou, E., Michailidou, C., Zarras, C., Vagdatli, E., Massa, E., Mouloudi, E., Pyrpasopoulou, A., Meletis, G., Protonotariou, E., Skoura, L., Metallidis, S., Karampatakis, T., Katsifa, E., Nikopoulou, A., Louka, A., Rizou, A., ... Vyzantiadis, T. A. (2024). Candida auris: Outbreak, surveillance and epidemiological monitoring in Northern Greece. Medical Mycology, 62(7), Article myae062. https://doi.org/10.1093/mmy/myae062

@article{f9a0066ffcbe415f8641756f21b69fa1,

title = "Candida auris: Outbreak, surveillance and epidemiological monitoring in Northern Greece",

abstract = "Candida auris is an emerging fungal pathogen associated with multi-drug resistance rates and widespread outbreaks in hospitals and healthcare units worldwide. Sequencing studies have revealed that different clonal lineages of the fungus seem to be prevalent among distinct geographical sites. The first case of C. auris in Northern Greece was reported in Thessaloniki in October 2022, almost 2 years after the first isolation in Greece (Athens 2019). The Mycology Laboratory of the Medical School of Aristotle University of Thessaloniki stands as the reference laboratory for fungal diseases in Northern Greece and a meticulous search for the yeast, in plenty of suspicious samples, has been run since 2019 in the Lab as well as a retrospective analysis of all its yeasts' collection, back to 2008, with negative results for the presence of C. auris. Here, are presented the findings concerning the outbreak and surveillance of C. auris in Northern Greece, mainly the region of Thessaloniki and the broader area of Macedonia, from October 2022 until August 2023. The isolates from Northern Greece continue to fall in Clade I and present with an almost equal and stable sensitivity profile until now.",

keywords = "Candida auris, Greece, epidemiology, monitoring, outbreak",

author = "Aikaterina Poulopoulou and Anna Sidiropoulou and Theopisti Sarmourli and Evaggelia Zachrou and Chrysi Michailidou and Charalampos Zarras and Eleni Vagdatli and Eleni Massa and Eleni Mouloudi and Athina Pyrpasopoulou and Georgios Meletis and Efthymia Protonotariou and Lemonia Skoura and Simeon Metallidis and Theodoros Karampatakis and Eleni Katsifa and Anna Nikopoulou and Alexandra Louka and Artemisia Rizou and Kostoula Arvaniti and Vassili Kouvelis and Andrew Borman and Emmanuel Roilides and Vyzantiadis, {Timoleon Achilleas}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2024.",

year = "2024",

month = jul,

day = "1",

doi = "10.1093/mmy/myae062",

language = "English",

volume = "62",

journal = "Medical Mycology",

issn = "1369-3786",

publisher = "Oxford University Press",

number = "7",

}

Poulopoulou, A, Sidiropoulou, A, Sarmourli, T, Zachrou, E, Michailidou, C, Zarras, C, Vagdatli, E, Massa, E, Mouloudi, E, Pyrpasopoulou, A, Meletis, G, Protonotariou, E, Skoura, L, Metallidis, S, Karampatakis, T, Katsifa, E, Nikopoulou, A, Louka, A, Rizou, A, Arvaniti, K, Kouvelis, V, Borman, A, Roilides, E & Vyzantiadis, TA 2024, 'Candida auris: Outbreak, surveillance and epidemiological monitoring in Northern Greece', Medical Mycology, vol. 62, no. 7, myae062. https://doi.org/10.1093/mmy/myae062

TY - JOUR

T1 - Candida auris

T2 - Outbreak, surveillance and epidemiological monitoring in Northern Greece

AU - Poulopoulou, Aikaterina

AU - Sidiropoulou, Anna

AU - Sarmourli, Theopisti

AU - Zachrou, Evaggelia

AU - Michailidou, Chrysi

AU - Zarras, Charalampos

AU - Vagdatli, Eleni

AU - Massa, Eleni

AU - Mouloudi, Eleni

AU - Pyrpasopoulou, Athina

AU - Meletis, Georgios

AU - Protonotariou, Efthymia

AU - Skoura, Lemonia

AU - Metallidis, Simeon

AU - Karampatakis, Theodoros

AU - Katsifa, Eleni

AU - Nikopoulou, Anna

AU - Louka, Alexandra

AU - Rizou, Artemisia

AU - Arvaniti, Kostoula

AU - Kouvelis, Vassili

AU - Borman, Andrew

AU - Roilides, Emmanuel

AU - Vyzantiadis, Timoleon Achilleas

PY - 2024/7/1

Y1 - 2024/7/1

N2 - Candida auris is an emerging fungal pathogen associated with multi-drug resistance rates and widespread outbreaks in hospitals and healthcare units worldwide. Sequencing studies have revealed that different clonal lineages of the fungus seem to be prevalent among distinct geographical sites. The first case of C. auris in Northern Greece was reported in Thessaloniki in October 2022, almost 2 years after the first isolation in Greece (Athens 2019). The Mycology Laboratory of the Medical School of Aristotle University of Thessaloniki stands as the reference laboratory for fungal diseases in Northern Greece and a meticulous search for the yeast, in plenty of suspicious samples, has been run since 2019 in the Lab as well as a retrospective analysis of all its yeasts' collection, back to 2008, with negative results for the presence of C. auris. Here, are presented the findings concerning the outbreak and surveillance of C. auris in Northern Greece, mainly the region of Thessaloniki and the broader area of Macedonia, from October 2022 until August 2023. The isolates from Northern Greece continue to fall in Clade I and present with an almost equal and stable sensitivity profile until now.

AB - Candida auris is an emerging fungal pathogen associated with multi-drug resistance rates and widespread outbreaks in hospitals and healthcare units worldwide. Sequencing studies have revealed that different clonal lineages of the fungus seem to be prevalent among distinct geographical sites. The first case of C. auris in Northern Greece was reported in Thessaloniki in October 2022, almost 2 years after the first isolation in Greece (Athens 2019). The Mycology Laboratory of the Medical School of Aristotle University of Thessaloniki stands as the reference laboratory for fungal diseases in Northern Greece and a meticulous search for the yeast, in plenty of suspicious samples, has been run since 2019 in the Lab as well as a retrospective analysis of all its yeasts' collection, back to 2008, with negative results for the presence of C. auris. Here, are presented the findings concerning the outbreak and surveillance of C. auris in Northern Greece, mainly the region of Thessaloniki and the broader area of Macedonia, from October 2022 until August 2023. The isolates from Northern Greece continue to fall in Clade I and present with an almost equal and stable sensitivity profile until now.

KW - Candida auris

KW - Greece

KW - epidemiology

KW - monitoring

KW - outbreak

UR - http://www.scopus.com/inward/record.url?scp=85198278848&partnerID=8YFLogxK

U2 - 10.1093/mmy/myae062

DO - 10.1093/mmy/myae062

M3 - Article

C2 - 38877671

AN - SCOPUS:85198278848

SN - 1369-3786

VL - 62

JO - Medical Mycology

JF - Medical Mycology

IS - 7

M1 - myae062

ER -

Candida auris: Outbreak, surveillance and epidemiological monitoring in Northern Greece

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this